Literature DB >> 9099166

Diphtheria and tetanus immunity among blood donors in Toronto.

L Yuan1, W Lau, J Thipphawong, M Kasenda, F Xie, J Bevilacqua.   

Abstract

OBJECTIVE: To determine the diphtheria and tetanus antitoxin levels among blood donors in Toronto.
DESIGN: Cross-sectional seroprevalence study.
SETTING: Two fixed-site blood-donation clinics in Toronto from September to November 1994. PARTICIPANTS: Blood donors 20 years of age or older were eligible to participate; of the 781 eligible donors, 710 (90.9%) participated in the study. MAIN OUTCOME MEASURES: Diphtheria and tetanus antitoxin levels and factors associated with disease susceptibility, such as vaccination history, country of birth, age and sex. A diphtheria antitoxin level lower than 0.01 lU/mL and a tetanus antitoxin level lower than 0.15 lU/mL were considered nonprotective.
RESULTS: Among the participants, 147 (20.7%) had a diphtheria antitoxin level in the nonprotective range, and 124 (17.5%) had a tetanus antitoxin level that was nonprotective. Increasing age and lack of written vaccination records were associated with susceptibility to the 2 diseases. Birth outside Canada was significantly related to tetanus susceptibility.
CONCLUSION: Adults over 50 years of age who did not know their vaccination history were the least likely to be protected against diphtheria and tetanus. The greatest benefit of any immunization strategy would be gained by targeting this group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099166      PMCID: PMC1227163     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  12 in total

1.  Persistence of a distinct Corynebacterium diphtheriae clonal group within two communities in the United States and Canada where diphtheria is endemic.

Authors:  C K Marston; F Jamieson; F Cahoon; G Lesiak; A Golaz; M Reeves; T Popovic
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Postoperative tetanus: a case report.

Authors:  K C Katz; S L Walmsley
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

3.  Immunity to diphtheria in a sample of the Canadian adult population.

Authors:  L Pelletier; P Duclos; P Gill; A Deforest
Journal:  Can J Infect Dis       Date:  1998-11

4.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

6.  A lethal case of generalized tetanus.

Authors:  Jocelyn A Srigley; Shariq Haider; Jennie Johnstone
Journal:  CMAJ       Date:  2011-02-22       Impact factor: 8.262

7.  Generalized tetanus.

Authors:  Kuang-Yu Niu; Yun-Kuan Lin
Journal:  CMAJ       Date:  2019-08-26       Impact factor: 8.262

8.  Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria.

Authors:  Leanne M Dewinter; Kathryn A Bernard; Marc G Romney
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects.

Authors:  F Ballereau; I Schrive; A Fisch; M Speich; H Laurichesse; S Tournade; M Rey
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

10.  Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Authors:  Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.